Welcome to our dedicated page for Amn Healthcare news (Ticker: AMN), a resource for investors and traders seeking the latest updates and insights on Amn Healthcare stock.
AMN Healthcare Services reports developments in healthcare workforce solutions and staffing services for healthcare organizations across the United States. Recurring updates cover quarterly results, earnings calls, revenue trends, gross margin, cash flow, debt, and outlook commentary across Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions.
Company news also tracks travel nurse staffing, labor disruption staffing, allied staffing, international nurse placement, search, managed service provider activity, language services, workforce technology, and market demand from healthcare systems. AMN's common stock trades on the New York Stock Exchange under the symbol AMN.
AMN Healthcare (NYSE: AMN) announced it has joined the AONL Foundation Corporate Advisory Council (CAC), a group of healthcare industry leaders focused on advancing nursing leadership, workforce innovation and the future of healthcare. AMN will be represented by Chief Nursing Executive Dr. Angelo Venditti and Head of Strategic Enterprise & Channel Partnerships Steven Endsley.
According to AMN Healthcare, the company will contribute workforce expertise, research and industry insights to support nurse leaders nationwide in areas such as strategic workforce planning, workforce analytics, staffing optimization, advisory services and leadership development. AONL Foundation leaders highlighted AMN as the first talent management organization to join the council.
AMN Healthcare (NYSE: AMN) released a white paper, Healthcare Staffing Projections Through 2030, outlining how aging demographics, rising chronic disease and rural access gaps are expected to drive sustained healthcare workforce demand. The analysis aggregates five years of AMN staffing engagements across nursing, allied health, physicians and advanced practitioners, combined with federal data, to project supply-demand trends through 2030.
Key findings include a projected physician shortage of up to 86,000 by 2036, with over 30% of active physicians already 60 or older. RN demand has eased from pandemic peaks, but filled positions fell faster, driving a nearly 7% decline in fill rates for the top five RN specialties from 2021 to 2025. In 2025, urban RN fill rates were nearly three times rural levels, and more than 7,700 primary care Health Professional Shortage Areas affected 76 million Americans, requiring an estimated 13,254 additional primary care providers. Allied health demand remains strong, with CT technologist demand more than doubling since 2021. The report also notes that AI-enabled automation could free 13–21% of nurses’ working hours, or about 240–400 hours per nurse annually.
AMN Healthcare (NYSE: AMN) reported Q2 2026 revenue of $673 million, up 2% year over year and down 51% sequentially, with net income of $21 million and GAAP diluted EPS of $0.53. Adjusted EBITDA was $73 million and adjusted diluted EPS $0.77, up 26% and 158% year over year, respectively.
Nurse and Allied Solutions revenue rose 11% year over year to $422 million, while Physician and Leadership Solutions fell 6% to $165 million and Technology and Workforce Solutions declined 15% to $87 million. Search revenue grew 27% year over year. Gross margin improved to 30.6% and adjusted EBITDA margin to 10.9%.
AMN ended the quarter with $362 million in cash and $750 million of total debt, a leverage ratio of 1.5x. Operating cash flow was ($190 million) in Q2, largely due to returning labor disruption client deposits. Q3 2026 guidance calls for revenue of $640–$655 million and adjusted EBITDA margin of 6.5–7.0%.
AMN Healthcare (NYSE:AMN) will hold its second quarter 2026 earnings conference call on Thursday, August 6, 2026, at 5:00 p.m. ET. The company expects to issue its Q2 2026 earnings news release the same day at approximately 4:15 p.m. ET after market close.
Investors can access a live webcast and replay via the AMN Healthcare investor relations website or join by telephone through advance registration or direct dial-in numbers.
AMN Healthcare (NYSE:AMN) announced a strategic partnership with Brightfield to expand healthcare workforce intelligence and market transparency. Brightfield's Talent Data Exchange (TDX) adds independent, third-party labor market data to AMN's proprietary clinical workforce insights, analytics, and real-time intelligence.
The collaboration supports AMN's WorkWise ecosystem, aiming to help health systems benchmark labor rates, validate workforce costs, align stakeholders, optimize workforce mix and spend, and shift from reactive staffing to proactive, data-backed workforce planning across clinical and non-clinical roles.
AMN Healthcare (AMN) appointed Kristy Willis as Chief Commercial Officer and Holly Novak as Chief People Officer, effective June 15, 2026.
Willis will lead an integrated commercial organization, while Novak will oversee human resources and AMN's long-term people strategy during its next phase of growth and innovation.
AMN Healthcare (NYSE:AMN) acquired Jaide Health, a real-time, AI-enabled medical interpretation and translation solution. The deal expands AMN Language Services’ support for Limited English Proficiency (LEP) patients across administrative steps before and after care, while keeping medically qualified human interpreters central for clinical, complex, and sensitive conversations.
The Jaide Health platform is already live with clients in multiple healthcare settings, and its team will join AMN Healthcare. Financial terms were not disclosed.
AMN Healthcare (AMN) elected Eric Palmer to its Board of Directors, effective May 1, 2026. Palmer brings over 25 years of leadership in healthcare services, benefits and insurance.
He previously served as CEO of Evernorth Health Services, leading revenue to over $200 billion, and as CFO of Cigna, where he helped drive the Express Scripts acquisition.
AMN Healthcare (NYSE: AMN) reported Q1 2026 revenue of $1.378 billion and adjusted EBITDA of $166.1 million. GAAP diluted EPS was $1.59; adjusted diluted EPS was $2.10. Nurse and Allied revenue was $1.127 billion, and labor disruption contributed $722 million of revenue.
Cash from operations was $562 million, quarter-end cash was $561 million, and total debt was $750 million. Q2 2026 revenue guidance is $620–$635 million with adjusted EBITDA margin of 6.7%–7.2%.
AMN Healthcare (NYSE: AMN) will report first quarter 2026 results and host a conference call on Thursday, May 7, 2026 at 5:00 p.m. ET. The company expects to issue an earnings release at approximately 4:15 p.m. ET the same day.
A live webcast and telephone participation are available via registration on the investor relations website, with a replay posted after the call. In 2025, AMN’s healthcare professionals reached over 13 million patients across more than 2,300 healthcare systems, including 93% of top systems.